U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Etomidate Injection
Status: Currently in Shortage
»Date first posted: 10/05/2022
»Therapeutic Categories: Anesthesia

Expand all

Avet Pharmaceuticals Inc (New 10/05/2022)

Company Contact Information:
855-228-9470

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/10mL carton of 10 (NDC 23155-160-41) Product available upon request

Avet Pharmaceuticals, Inc. (New 10/05/2022)

Company Contact Information:
855-228-9470

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg/20 mL carton of 10 (NDC 23155-160-42) Product available upon request

Caplin Steriles, Ltd. (Revised 11/14/2022)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 10 mL vial (NDC 65219-445-10) 3 month expiry (2/28/2023 expiry) dating available by request. Marketed by Fresenius Kabi; Check wholesalers for inventory
2 mg/mL, 20 mL vial (NDC 65219-447-20) Available Marketed by Fresenius Kabi
2 mg/mL, 10 mL vial (NDC 25021-674-10) Available Marketed by Sagent
2 mg/mL, 20 mL vial (NDC 25021-674-20) Available Marketed by Sagent

Eugia US, LLC (formerly AuroMedics Pharma LLC) [mfd. by Eugia Pharma Specialties, Ltd.) (Revised 11/15/2022)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 10 mL vial (NDC 55150-221-10) Currently on backorder - next shipment end December 2022 Next shipment anticipated in Oct. Other
2 mg/mL, 20 mL vial (NDC 55150-222-20) Currently on backorder - next shipment end December 2022 Next shipment TBD Other

Gland Pharma Limited (New 10/05/2022)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 10 mL vial (NDC 72266-146-10) Pending information Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
2 mg/mL, 20 mL vial (NDC 72266-147-10) Pending information Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

Hikma Pharmaceuticals, LLC (formerly West-Ward) (New 10/05/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 10 mL vial (NDC 0143-9506-10) Currently on backorder Demand increase for the drug
2 mg/mL, 20 mL vial (NDC 0143-9507-10) Currently on backorder Demand increase for the drug
2 mg/mL, 10 mL vial (NDC 0143-9310-10), Novaplus Pending information
2 mg/mL, 20 mL vial (NDC 0143-9311-10), Novaplus Pending information
2 mg/mL, 10 mL vial (NDC 72572-160-10) Pending information Distributed by Civica
2 mg/mL, 20 mL vial (NDC 72572-161-10) Pending information Distributed by Civica

Hospira, Inc., a Pfizer Company (Reverified 11/10/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Amidate, 2 mg/mL, 10 mL vial (NDC 0409-6695-01) Next delivery: March 2023; Estimated recovery: December 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
Amidate, 2 mg/mL, 20 mL vial (NDC 0409-6695-02) Next delivery: February 2023; Estimated recovery: March 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other

Mylan Pharmaceuticals Inc., a Viatris Company (Reverified 11/23/2022)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 10 mL vial (NDC 67457-902-10) Q1 2023 Demand increase for the drug
2 mg/mL, 20 mL vial (NDC 67457-903-20) Q1 2023 Demand increase for the drug
Back to Top